Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	GTPase binding	BICD2 RGPD8 SPTBN1 PIH1D2 TRIP11 GCC2 AFDN AKAP13 GOLGA4 IPO11	1.03e-04	360	127	10	GO:0051020
GeneOntologyMolecularFunction	small GTPase binding	BICD2 RGPD8 PIH1D2 TRIP11 GCC2 AFDN AKAP13 GOLGA4 IPO11	2.16e-04	321	127	9	GO:0031267
GeneOntologyBiologicalProcess	establishment of protein localization to plasma membrane	GRIPAP1 SPTBN1 OPTN GCC2 AFDN GOLGA4	6.79e-06	76	125	6	GO:0061951
GeneOntologyCellularComponent	neuron to neuron synapse	EPHB2 SPTBN1 EIF3E FAM81A DST PPP3R1 AKAP9 PLPPR4 EIF4G2 AFDN PLCB4 DMD	8.41e-05	523	127	12	GO:0098984
GeneOntologyCellularComponent	cell-cell contact zone	MYH1 DST PIK3CA CTNNA3 AFDN	2.72e-04	94	127	5	GO:0044291
GeneOntologyCellularComponent	A band	MYH1 SPTBN1 DST NBR1	2.81e-04	52	127	4	GO:0031672
GeneOntologyCellularComponent	midbody	CENPF CNTRL SPART VPS37B ANLN RASGEF1B KIF14	4.22e-04	222	127	7	GO:0030496
GeneOntologyCellularComponent	postsynaptic density	SPTBN1 EIF3E FAM81A DST AKAP9 PLPPR4 EIF4G2 AFDN PLCB4 DMD	4.37e-04	451	127	10	GO:0014069
GeneOntologyCellularComponent	perinuclear region of cytoplasm	CALCOCO2 RGPD8 GBP7 CENPF CNTRL COPS3 RAD50 MTMR6 OPTN DST PIK3CA AKAP13 DMD GOLGA1 EPHA5	5.51e-04	934	127	15	GO:0048471
GeneOntologyCellularComponent	asymmetric synapse	SPTBN1 EIF3E FAM81A DST AKAP9 PLPPR4 EIF4G2 AFDN PLCB4 DMD	6.75e-04	477	127	10	GO:0032279
GeneOntologyCellularComponent	postsynaptic early endosome	GRIPAP1 EEA1	7.54e-04	7	127	2	GO:0098842
GeneOntologyCellularComponent	intercalated disc	MYH1 DST PIK3CA CTNNA3	7.84e-04	68	127	4	GO:0014704
GeneOntologyCellularComponent	sarcomere	MYH1 MYH4 SPTBN1 DST SYNE2 DMD NBR1	8.31e-04	249	127	7	GO:0030017
GeneOntologyCellularComponent	outer acrosomal membrane	TRIP11 IFT88	1.00e-03	8	127	2	GO:0002081
GeneOntologyCellularComponent	postsynaptic specialization	SPTBN1 EIF3E FAM81A DST AKAP9 PLPPR4 EIF4G2 AFDN PLCB4 DMD	1.01e-03	503	127	10	GO:0099572
GeneOntologyCellularComponent	postsynapse	EPHB2 GRIPAP1 SPTBN1 EIF3E FAM81A ELMO1 DST PPP3R1 AKAP9 PLPPR4 EIF4G2 AFDN PLCB4 EEA1 DMD	1.32e-03	1018	127	15	GO:0098794
GeneOntologyCellularComponent	myofibril	MYH1 MYH4 SPTBN1 DST SYNE2 DMD NBR1	1.42e-03	273	127	7	GO:0030016
GeneOntologyCellularComponent	acrosomal membrane	TRIP11 IFT88 CCDC136	1.58e-03	38	127	3	GO:0002080
GeneOntologyCellularComponent	axoneme	CENPF DYNC2H1 CEP162 CNTRL CFAP141 IFT88	1.68e-03	207	127	6	GO:0005930
GeneOntologyCellularComponent	ciliary plasm	CENPF DYNC2H1 CEP162 CNTRL CFAP141 IFT88	1.72e-03	208	127	6	GO:0097014
GeneOntologyCellularComponent	contractile muscle fiber	MYH1 MYH4 SPTBN1 DST SYNE2 DMD NBR1	2.00e-03	290	127	7	GO:0043292
Domain	GRIP_dom	RGPD8 TRIP11 GCC2 GOLGA1 GOLGA4 RGPD5	5.55e-11	12	120	6	IPR000237
Domain	GRIP	RGPD8 TRIP11 GCC2 GOLGA1 GOLGA4 RGPD5	5.55e-11	12	120	6	PS50913
Domain	Grip	RGPD8 GCC2 GOLGA1 GOLGA4 RGPD5	4.51e-09	11	120	5	SM00755
Domain	GRIP	RGPD8 GCC2 GOLGA1 GOLGA4 RGPD5	4.51e-09	11	120	5	PF01465
Domain	-	RGPD8 GCC2 GOLGA1 GOLGA4	3.30e-07	10	120	4	1.10.220.60
Domain	PH_12	ELMO1 ELMO3 PLCL1	5.10e-06	6	120	3	PF16457
Domain	Spectrin	SPTBN1 DST SYNE2 DMD	1.31e-05	23	120	4	PF00435
Domain	ACTININ_2	SPTBN1 DST SYNE2 DMD	1.31e-05	23	120	4	PS00020
Domain	ACTININ_1	SPTBN1 DST SYNE2 DMD	1.31e-05	23	120	4	PS00019
Domain	Actinin_actin-bd_CS	SPTBN1 DST SYNE2 DMD	1.31e-05	23	120	4	IPR001589
Domain	Spectrin_repeat	SPTBN1 DST SYNE2 DMD	3.40e-05	29	120	4	IPR002017
Domain	SPEC	SPTBN1 DST SYNE2 DMD	5.07e-05	32	120	4	SM00150
Domain	Spectrin/alpha-actinin	SPTBN1 DST SYNE2 DMD	5.07e-05	32	120	4	IPR018159
Domain	-	SPTBN1 DST CEP95 SYNE2 DMD	9.34e-05	71	120	5	1.10.418.10
Domain	PH_dom-like	RGPD8 SPTBN1 RGS12 ELMO1 MTMR6 ELMO3 ANLN AKAP13 PLCB4 PLCL1 RGPD5	9.55e-05	426	120	11	IPR011993
Domain	CH-domain	SPTBN1 DST CEP95 SYNE2 DMD	1.21e-04	75	120	5	IPR001715
Domain	DUF3361	ELMO1 ELMO3	1.22e-04	3	120	2	IPR024574
Domain	DUF3361	ELMO1 ELMO3	1.22e-04	3	120	2	PF11841
Domain	-	RGPD8 SPTBN1 RGS12 ELMO1 MTMR6 ELMO3 ANLN AKAP13 PLCB4 PLCL1	2.17e-04	391	120	10	2.30.29.30
Domain	MA3	EIF4G2 EIF4G3	6.04e-04	6	120	2	SM00544
Domain	MA3	EIF4G2 EIF4G3	6.04e-04	6	120	2	PF02847
Domain	ELMO_CED12	ELMO1 ELMO3	6.04e-04	6	120	2	PF04727
Domain	Initiation_fac_eIF4g_MI	EIF4G2 EIF4G3	6.04e-04	6	120	2	IPR003891
Domain	ELMO	ELMO1 ELMO3	6.04e-04	6	120	2	PS51335
Domain	MI	EIF4G2 EIF4G3	6.04e-04	6	120	2	PS51366
Domain	ELMO_dom	ELMO1 ELMO3	6.04e-04	6	120	2	IPR006816
Domain	HMG_box_dom	PMS1 SOX13 FAM81A KMT2C	8.11e-04	65	120	4	IPR009071
Domain	CH	SPTBN1 DST SYNE2 DMD	8.11e-04	65	120	4	SM00033
Domain	eIF5C	EIF4G2 EIF4G3	8.42e-04	7	120	2	SM00515
Domain	Rab_bind	RGPD8 GCC2	8.42e-04	7	120	2	PF16704
Domain	GCC2_Rab_bind	RGPD8 GCC2	8.42e-04	7	120	2	IPR032023
Domain	W2	EIF4G2 EIF4G3	8.42e-04	7	120	2	PF02020
Domain	W2	EIF4G2 EIF4G3	8.42e-04	7	120	2	PS51363
Domain	W2_domain	EIF4G2 EIF4G3	8.42e-04	7	120	2	IPR003307
Domain	CH	SPTBN1 DST SYNE2 DMD	1.07e-03	70	120	4	PF00307
Domain	CH	SPTBN1 DST SYNE2 DMD	1.25e-03	73	120	4	PS50021
Domain	MIF4G	EIF4G2 EIF4G3	1.78e-03	10	120	2	SM00543
Domain	MIF4G	EIF4G2 EIF4G3	1.78e-03	10	120	2	PF02854
Domain	MIF4G-like_typ-3	EIF4G2 EIF4G3	1.78e-03	10	120	2	IPR003890
Domain	Ran_BP1	RGPD8 RGPD5	2.59e-03	12	120	2	PF00638
Domain	RANBD1	RGPD8 RGPD5	2.59e-03	12	120	2	PS50196
Domain	RanBD	RGPD8 RGPD5	3.05e-03	13	120	2	SM00160
Domain	Ran_bind_dom	RGPD8 RGPD5	3.05e-03	13	120	2	IPR000156
Domain	RECEPTOR_TYR_KIN_V_2	EPHB2 EPHA5	3.54e-03	14	120	2	PS00791
Domain	RECEPTOR_TYR_KIN_V_1	EPHB2 EPHA5	3.54e-03	14	120	2	PS00790
Domain	Tyr_kinase_rcpt_V_CS	EPHB2 EPHA5	3.54e-03	14	120	2	IPR001426
Domain	EphA2_TM	EPHB2 EPHA5	3.54e-03	14	120	2	PF14575
Domain	Ephrin_rcpt_lig-bd_dom	EPHB2 EPHA5	3.54e-03	14	120	2	IPR001090
Domain	Eph_TM	EPHB2 EPHA5	3.54e-03	14	120	2	IPR027936
Domain	EPH_lbd	EPHB2 EPHA5	3.54e-03	14	120	2	SM00615
Domain	Ephrin_lbd	EPHB2 EPHA5	3.54e-03	14	120	2	PF01404
Domain	Tyr_kinase_ephrin_rcpt	EPHB2 EPHA5	3.54e-03	14	120	2	IPR016257
Domain	EPH_LBD	EPHB2 EPHA5	3.54e-03	14	120	2	PS51550
Domain	EF-hand_like	PLCB4 PLCL1	4.07e-03	15	120	2	PF09279
Domain	PI-PLC-Y	PLCB4 PLCL1	4.07e-03	15	120	2	PF00387
Domain	-	EIF4G2 EIF4G3	4.07e-03	15	120	2	1.25.40.180
Domain	PLCYc	PLCB4 PLCL1	4.07e-03	15	120	2	SM00149
Domain	PLipase_C_Pinositol-sp_Y	PLCB4 PLCL1	4.07e-03	15	120	2	IPR001711
Domain	Myosin_N	MYH1 MYH4	4.07e-03	15	120	2	PF02736
Domain	PIPLC_Y_DOMAIN	PLCB4 PLCL1	4.07e-03	15	120	2	PS50008
Domain	MIF4-like	EIF4G2 EIF4G3	4.07e-03	15	120	2	IPR016021
Domain	Myosin_N	MYH1 MYH4	4.07e-03	15	120	2	IPR004009
Domain	PI-PLC_fam	PLCB4 PLCL1	4.07e-03	15	120	2	IPR001192
Domain	PLC_EF-hand-like	PLCB4 PLCL1	4.07e-03	15	120	2	IPR015359
Domain	PINT	EIF3E COPS3	4.63e-03	16	120	2	SM00088
Domain	HMG_box	PMS1 SOX13 KMT2C	4.80e-03	53	120	3	PF00505
Domain	HMG	PMS1 SOX13 KMT2C	5.05e-03	54	120	3	SM00398
Domain	PCI_dom	EIF3E COPS3	5.23e-03	17	120	2	IPR000717
Domain	PCI	EIF3E COPS3	5.23e-03	17	120	2	PF01399
Domain	Myosin_tail_1	MYH1 MYH4	5.86e-03	18	120	2	PF01576
Domain	Myosin_tail	MYH1 MYH4	5.86e-03	18	120	2	IPR002928
Domain	ZF_ZZ_2	DMD NBR1	5.86e-03	18	120	2	PS50135
Domain	PI-PLC-X	PLCB4 PLCL1	5.86e-03	18	120	2	PF00388
Domain	ZF_ZZ_1	DMD NBR1	5.86e-03	18	120	2	PS01357
Domain	PLCXc	PLCB4 PLCL1	5.86e-03	18	120	2	SM00148
Domain	ZZ	DMD NBR1	5.86e-03	18	120	2	PF00569
Domain	ARM-type_fold	HSPBP1 ELMO1 ELMO3 PIK3CA EIF4G2 EIF4G3 IPO11	6.32e-03	339	120	7	IPR016024
Pathway	REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS	SPTBN1 TRIP11 PIK3CA GOLGB1	7.24e-06	19	96	4	M41732
Pathway	KEGG_MEDICUS_REFERENCE_TBK1_MEDIATED_AUTOPHAGOSOME_FORMATION	CALCOCO2 OPTN NBR1	3.55e-05	10	96	3	M47745
Pathway	REACTOME_FLT3_SIGNALING_IN_DISEASE	SPTBN1 TRIP11 PIK3CA GOLGB1	3.65e-05	28	96	4	M41724
Pathway	KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR	CALCOCO2 OPTN NBR1	1.06e-04	14	96	3	M47975
Pathway	KEGG_VIRAL_MYOCARDITIS	MYH1 MYH4 EIF4G2 DMD EIF4G3	1.12e-04	70	96	5	M12294
Pathway	KEGG_MEDICUS_REFERENCE_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION	CALCOCO2 OPTN NBR1	1.94e-04	17	96	3	M47742
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	CENPF SPTBN1 PCDHB6 COPS3 PRPF8 RGS12 KMT2C VPS13D TAOK3 GTF3C1 PLCB4 TAF4 TOP3B GOLGA1 IPO11	5.18e-10	497	128	15	36774506
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	CALCOCO2 ANGPT2 CCDC110 SPTBN1 CNTRL NAP1L1 ISL1 HSPBP1 VPS13D PPP3R1 IFT88 EEA1 FAR1 GOLGA4 GOLGB1	2.88e-09	564	128	15	21565611
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TFEB CEP162 SPTBN1 TRIP11 RGS12 VPS13D OPTN DST AKAP9 ANLN CEP95 SYNE2 KIF14 AFDN AKAP13 EIF4G3 GOLGA4 GOLGB1	3.03e-09	861	128	18	36931259
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	CALCOCO2 KIF27 CENPF DYNC2H1 SPTBN1 EIF3E NAP1L1 COPS3 HSPBP1 PRPF8 RAD50 GTF3C1 PABPN1 EIF4G2 HSD17B12 KIF14 AFDN EEA1 FAR1 FUBP3 NBR1 GOLGA4	1.19e-08	1425	128	22	30948266
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH1 MYH4 RGPD8 CENPF SPTBN1 CNTRL CCDC150 PRPF8 PGK2 DST GTF3C1 IFT88 FAM186A SYNE2 TAF4 EEA1 DMD EIF4G3 FUBP3 TOP3B GOLGB1 RGPD5	1.47e-08	1442	128	22	35575683
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	GRIPAP1 CENPF SPTBN1 DST AKAP9 DMD GOLGA4 RGPD5	1.61e-08	120	128	8	31413325
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	PMS1 DYNC2H1 SPTBN1 CNTRL EIF3E ZNF622 CASP10 PRPF8 TRIP11 RAD50 RHOBTB1 SYNE2 KIF14 TFB2M DMD GOLGB1	1.99e-08	754	128	16	35906200
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RGPD8 CENPF SPTBN1 TRIP11 FAM81A RAD50 DST AKAP9 PLPPR4 SYNE2 AFDN PLCL1 TAF4 TOP3B GOLGA1 GOLGA4 GOLGB1	9.94e-08	963	128	17	28671696
Pubmed	The trans-Golgi network GRIP-domain proteins form alpha-helical homodimers.	GCC2 GOLGA1 GOLGA4	1.94e-07	4	128	3	15654769
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	SPTBN1 EIF3E NAP1L1 ZNF622 COPS3 PRPF8 RAD50 CUL5 OPTN DST GTF3C1 BTF3 SYNE2 EIF4G2 HSD17B12 KIF14 ATP13A3 FAR1 FUBP3 IPO11	3.24e-07	1440	128	20	30833792
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	GRIPAP1 DYNC2H1 EIF3E CCDC150 COPS3 HSPBP1 PRPF8 TRIP11 RAD50 SLC9C1 IFT88 GCC2 AFDN KATNIP TFB2M EEA1 CCDC144A PMFBP1 IPO11	3.90e-07	1321	128	19	27173435
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	EPHB2 UBR1 ZNF384 GRIPAP1 SPTBN1 EIF3E SPART COPS3 PRPF8 RAD50 OPTN ANLN BTF3 SYNE2 EIF4G2 AFDN FUBP3 GOLGB1 IPO11	6.53e-07	1367	128	19	32687490
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	CENPF SPTBN1 EIF3E NAP1L1 PRPF8 RAD50 DST GTF3C1 SYNE2 KIF14 AFDN EIF4G3 FUBP3	9.41e-07	653	128	13	22586326
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	GRIPAP1 SPTBN1 TRIP11 OPTN DST ANLN BTF3 EEA1 GOLGA4 GOLGB1	9.59e-07	360	128	10	33111431
Pubmed	The PB1 protein of influenza A virus inhibits the innate immune response by targeting MAVS for NBR1-mediated selective autophagic degradation.	CALCOCO2 OPTN NBR1	9.66e-07	6	128	3	33577621
Pubmed	Interaction of Arl1-GTP with GRIP domains recruits autoantigens Golgin-97 and Golgin-245/p230 onto the Golgi.	GCC2 GOLGA1 GOLGA4	9.66e-07	6	128	3	12972563
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	CENPF SPTBN1 DST AKAP9 DMD CCDC136 GOLGA4	1.54e-06	151	128	7	17043677
Pubmed	GPAT2 is required for piRNA biogenesis, transposon silencing, and maintenance of spermatogonia in mice†.	SYCP3 TDRD1 GPAT2	1.69e-06	7	128	3	30951587
Pubmed	A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.	CALCOCO2 DYNC2H1 OPTN CEP95 EIF4G2 KIF14 FUBP3 NBR1 EPHA5	1.92e-06	302	128	9	30561431
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	BICD2 TFEB GRIPAP1 RGPD8 DYNC2H1 SPART TRIP11 SOX13 RAD50 KIF14 POLK GOLGB1	1.95e-06	588	128	12	38580884
Pubmed	Identification of targets for calcium signaling through the copine family of proteins. Characterization of a coiled-coil copine-binding motif.	BICD2 CENPF CEP162 SPTBN1	2.09e-06	25	128	4	12522145
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	UBR1 ZNF384 SPTBN1 EIF3E NAP1L1 COPS3 PRPF8 RAD50 DST GTF3C1 PABPN1 ANLN EIF4G2 AFDN AKAP13 FAR1 FUBP3 GOLGA4	2.45e-06	1353	128	18	29467282
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	HK3 GBP7 CEP162 SPTBN1 CNTRL KMT2C MTMR6 TAOK3 ANLN EIF4G2 TFB2M GFPT2 POLK SUCO FUBP3 GOLGB1	2.53e-06	1084	128	16	11544199
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	RGPD8 PRPF8 RAD50 DST FAM186A EEA1 DMD GOLGB1	2.66e-06	234	128	8	36243803
Pubmed	Critical role of mitochondrial ubiquitination and the OPTN-ATG9A axis in mitophagy.	CALCOCO2 OPTN NBR1	2.69e-06	8	128	3	32556086
Pubmed	Long noncoding RNA lncMREF promotes myogenic differentiation and muscle regeneration by interacting with the Smarca5/p300 complex.	MYH1 MYH4 DMD	2.69e-06	8	128	3	36200826
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	DYNC2H1 NAP1L1 RGS12 KMT2C MTMR6 DST SYNE2 GFPT2 DMD	3.25e-06	322	128	9	26514267
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	BICD2 GRIPAP1 CEP162 CNTRL NAP1L1 RGS12 RAD50 MTMR6 CEP95 BTF3 EIF4G2 KIF14 AFDN TFB2M	3.37e-06	853	128	14	28718761
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	BICD2 RGPD8 CENPF RAD50 DST GTF3C1 GCC2 KIF14 FAR1 GOLGB1	3.63e-06	418	128	10	34709266
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	BICD2 REX1BD MYH4 DYNC2H1 EIF3E COPS3 PRPF8 RAD50 CUL5 OPTN GCC2 BTF3 EIF4G2 EIF4G3 RGPD5	4.66e-06	1005	128	15	19615732
Pubmed	A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.	CENPF SPTBN1 ANLN KIF14 EIF4G3 GOLGB1	5.20e-06	118	128	6	30979931
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	MYH1 GRIPAP1 SPTBN1 EIF3E NAP1L1 PRPF8 DST PPP3R1 BTF3 EIF4G2 DMD	5.23e-06	538	128	11	28524877
Pubmed	Bioinformatics and cellular signaling.	NAP1L1 ELMO1 ELMO3 PIK3CA GCC2 EIF4G2 AKAP13	5.31e-06	182	128	7	15102471
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	CALCOCO2 SPART HSPBP1 PRPF8 MTMR6 OPTN DST ANLN BTF3 SYNE2 HSD17B12 AKAP13 PLCB4 NAA40 EEA1 TOP3B NBR1	5.83e-06	1297	128	17	33545068
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NAP1L1 RAD50 KMT2C MTMR6 GTF3C1 ANLN KIF14 AFDN TAF4 TAF7 RGPD5	6.33e-06	549	128	11	38280479
Pubmed	Defining the membrane proteome of NK cells.	CALCOCO2 CNTRL EIF3E NAP1L1 PRPF8 ELMO1 RAD50 GTF3C1 GCC2 EIF4G2 KIF14 AKAP13 ATP13A3 FUBP3 NBR1 GOLGB1	6.49e-06	1168	128	16	19946888
Pubmed	Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease.	CALCOCO2 OPTN NBR1	7.86e-06	11	128	3	32093570
Pubmed	SKP2 attenuates NF-κB signaling by mediating IKKβ degradation through autophagy.	CALCOCO2 OPTN NBR1	7.86e-06	11	128	3	29474632
Pubmed	VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation.	CALCOCO2 OPTN NBR1	7.86e-06	11	128	3	37352355
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	BICD2 SPTBN1 NAP1L1 SPART TRIP11 VPS13D DST GCC2 SYNE2 EIF4G2 GOLGA4	8.71e-06	568	128	11	37774976
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	PMS1 DYNC2H1 SPTBN1 SPART ZNF622 HSPBP1 PRPF8 AKAP9 SYNE2 EIF4G2 AKAP13 FAR1 EIF4G3 SUCO TOP3B NBR1 GOLGA4 GOLGB1	8.99e-06	1487	128	18	33957083
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	PMS1 ZNF384 NAP1L1 SPART ZNF622 PRPF8 TRIP11 RAD50 DST BTF3 EIF4G2 NAA40 EIF4G3 GOLGB1	9.42e-06	934	128	14	33916271
Pubmed	Biasing the conformation of ELMO2 reveals that myoblast fusion can be exploited to improve muscle regeneration.	ELMO1 ELMO3 DMD	1.05e-05	12	128	3	36400788
Pubmed	Functional proteomics mapping of a human signaling pathway.	CALCOCO2 SPTBN1 EIF3E SPART SOX13 CUL5 OPTN DST EIF4G2 AFDN GOLGB1	1.26e-05	591	128	11	15231748
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	RAD50 KMT2C CEP95 CTNNA3 CARD11 FAR1 GOLGB1	1.27e-05	208	128	7	33230847
Pubmed	Characterization of the INT6 mammary tumor gene product.	EIF3E GOLGB1	1.34e-05	2	128	2	9260927
Pubmed	Male mouse meiotic chromosome cores deficient in structural proteins SYCP3 and SYCP2 align by homology but fail to synapse and have possible impaired specificity of chromatin loop attachment.	SYCP3 SYCP2	1.34e-05	2	128	2	15237206
Pubmed	Mouse SYCP2 is required for synaptonemal complex assembly and chromosomal synapsis during male meiosis.	SYCP3 SYCP2	1.34e-05	2	128	2	16717126
Pubmed	Growth and muscle defects in mice lacking adult myosin heavy chain genes.	MYH1 MYH4	1.34e-05	2	128	2	9382868
Pubmed	Postnatal myosin heavy chain isoform expression in normal mice and mice null for IIb or IId myosin heavy chains.	MYH1 MYH4	1.34e-05	2	128	2	11150240
Pubmed	Suppression of cell migration by phospholipase C-related catalytically inactive protein-dependent modulation of PI3K signalling.	PIK3CA PLCL1	1.34e-05	2	128	2	28710365
Pubmed	GMAP210 and IFT88 are present in the spermatid golgi apparatus and participate in the development of the acrosome-acroplaxome complex, head-tail coupling apparatus and tail.	TRIP11 IFT88	1.34e-05	2	128	2	21337470
Pubmed	Automatic and unbiased segmentation and quantification of myofibers in skeletal muscle.	IFT88 DMD	1.34e-05	2	128	2	34083673
Pubmed	Cleavage of eukaryotic translation initiation factor 4GII within foot-and-mouth disease virus-infected cells: identification of the L-protease cleavage site in vitro.	EIF4G2 EIF4G3	1.34e-05	2	128	2	15016848
Pubmed	A role for the Golgi matrix protein giantin in ciliogenesis through control of the localization of dynein-2.	DYNC2H1 GOLGB1	1.34e-05	2	128	2	24046448
Pubmed	Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice.	MYH1 MYH4	1.34e-05	2	128	2	11744674
Pubmed	Stress granule homeostasis is modulated by TRIM21-mediated ubiquitination of G3BP1 and autophagy-dependent elimination of stress granules.	CALCOCO2 OPTN NBR1	1.36e-05	13	128	3	36692217
Pubmed	A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.	GRIPAP1 CENPF CNTRL SPART AKAP9 GCC2 ATP13A3 GOLGB1	1.55e-05	298	128	8	32353859
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	GRIPAP1 CENPF CNTRL EIF3E SPART RAD50 AKAP9 PABPN1 GCC2 ATP13A3 GOLGB1 IPO11	2.37e-05	754	128	12	33060197
Pubmed	Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma.	SPTBN1 EIF3E PRPF8 DST AKAP9 FAR1 EIF4G3 FUBP3	3.15e-05	329	128	8	34316702
Pubmed	mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells.	DST GTF3C1 SYNE2 HSD17B12 CCDC136	3.22e-05	98	128	5	34943047
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PMS1 EFL1 CEP162 SPTBN1 MTMR6 PPP3R1 AKAP9 SYNE2 HSD17B12 KIF14 DMD TOP3B NBR1 GOLGA4	3.39e-05	1049	128	14	27880917
Pubmed	Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation.	MYH1 MYH4	4.02e-05	3	128	2	26059207
Pubmed	Simultaneous loss of skeletal muscle myosin heavy chain IIx and IIb causes severe skeletal muscle hypoplasia in postnatal mice.	MYH1 MYH4	4.02e-05	3	128	2	36515178
Pubmed	Identification of ocular regulatory functions of core histone variant H3.2.	EPHB2 EPHA5	4.02e-05	3	128	2	36529279
Pubmed	The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy.	CALCOCO2 OPTN	4.02e-05	3	128	2	26266977
Pubmed	Mouse Tudor Repeat-1 (MTR-1) is a novel component of chromatoid bodies/nuages in male germ cells and forms a complex with snRNPs.	SYCP3 TDRD1	4.02e-05	3	128	2	14550528
Pubmed	FUBP3 Degrades the Porcine Epidemic Diarrhea Virus Nucleocapsid Protein and Induces the Production of Type I Interferon.	CALCOCO2 FUBP3	4.02e-05	3	128	2	35695513
Pubmed	Pathogenic variants of DYNC2H1, KIAA0556, and PTPN11 associated with hypothalamic hamartoma.	DYNC2H1 KATNIP	4.02e-05	3	128	2	31197031
Pubmed	Human Asunder promotes dynein recruitment and centrosomal tethering to the nucleus at mitotic entry.	BICD2 CENPF	4.02e-05	3	128	2	23097494
Pubmed	A conserved filamentous assembly underlies the structure of the meiotic chromosome axis.	SYCP3 SYCP2	4.02e-05	3	128	2	30657449
Pubmed	Baicalein Activates Parkin-Dependent Mitophagy through NDP52 and OPTN.	CALCOCO2 OPTN	4.02e-05	3	128	2	35406696
Pubmed	Infertility and aneuploidy in mice lacking a type IA DNA topoisomerase III beta.	SYCP3 TOP3B	4.02e-05	3	128	2	12591952
Pubmed	A novel dynein light intermediate chain colocalizes with the retrograde motor for intraflagellar transport at sites of axoneme assembly in chlamydomonas and Mammalian cells.	DYNC2H1 IFT88	4.02e-05	3	128	2	12802074
Pubmed	Ephrin reverse signaling controls palate fusion via a PI3 kinase-dependent mechanism.	EPHB2 PIK3CA	4.02e-05	3	128	2	21246652
Pubmed	Role of Nesprin-2 and RanBP2 in BICD2-associated brain developmental disorders.	BICD2 SYNE2	4.02e-05	3	128	2	36930595
Pubmed	A role for Regulator of G protein Signaling-12 (RGS12) in the balance between myoblast proliferation and differentiation.	RGS12 DMD	4.02e-05	3	128	2	31408461
Pubmed	Phosphorylation screening identifies translational initiation factor 4GII as an intracellular target of Ca(2+)/calmodulin-dependent protein kinase I.	EIF4G2 EIF4G3	4.02e-05	3	128	2	14507913
Pubmed	A conserved HEAT domain within eIF4G directs assembly of the translation initiation machinery.	EIF4G2 EIF4G3	4.02e-05	3	128	2	11172724
Pubmed	Specific isomyosin proportions in hyperexcitable and physiologically denervated mouse muscle.	MYH4 DMD	4.02e-05	3	128	2	15013776
Pubmed	Developmental expression of BPAG1-n: insights into the spastic ataxia and gross neurologic degeneration in dystonia musculorum mice.	ISL1 DST	4.02e-05	3	128	2	9242412
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	SPTBN1 EIF3E NAP1L1 PRPF8 PABPN1 BTF3 RAVER2 EIF4G2 TFB2M EIF4G3 FUBP3 TOP3B	4.57e-05	807	128	12	22681889
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	CENPF NAP1L1 PRPF8 ANLN EIF4G2 NBR1 GOLGB1	4.78e-05	256	128	7	33397691
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	CALCOCO2 NAP1L1 CUL5 KMT2C AKAP9 EIF4G2 AKAP13 MAML2 GFPT2 TAF4 IPO11	5.10e-05	689	128	11	36543142
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	SLC25A33 EIF3E NAP1L1 HSPBP1 GTF3C1 PABPN1 EIF4G2 EIF4G3 TOP3B	5.63e-05	462	128	9	31138677
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ZNF384 NAP1L1 COPS3 ELMO1 RAD50 KMT2C TAOK3 GTF3C1 ANLN BTF3 EIF4G2 TAF4 FUBP3 IPO11	5.82e-05	1103	128	14	34189442
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	ZNF384 SPTBN1 EIF3E ZNF622 PRPF8 KMT2C PABPN1 HSD17B12 AFDN FUBP3 GOLGB1	6.75e-05	711	128	11	33022573
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	MYH1 MYH4 RGPD8 NAP1L1 PRPF8 FAM81A DST EIF4G2 KIF14 DMD FUBP3 RGPD5	7.00e-05	844	128	12	25963833
Pubmed	A new role for the calcineurin/NFAT pathway in neonatal myosin heavy chain expression via the NFATc2/MyoD complex during mouse myogenesis.	MYH1 MYH4 DMD	7.12e-05	22	128	3	24301466
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	BICD2 SPART ZNF622 PRPF8 BTF3 FER AKAP13 TAF7 EIF4G3 FUBP3 TOP3B	7.93e-05	724	128	11	36232890
Pubmed	The trans-Golgi network golgin, GCC185, is required for endosome-to-Golgi transport and maintenance of Golgi structure.	GCC2 GOLGA1	8.02e-05	4	128	2	17488291
Pubmed	RYK, a catalytically inactive receptor tyrosine kinase, associates with EphB2 and EphB3 but does not interact with AF-6.	EPHB2 AFDN	8.02e-05	4	128	2	11956217
Pubmed	Three linked myosin heavy chain genes clustered within 370 kb of each other show independent transcriptional and post-transcriptional regulation during differentiation of a mouse muscle cell line.	MYH1 MYH4	8.02e-05	4	128	2	1985022
Pubmed	What are those cilia doing in the neural tube?	DYNC2H1 IFT88	8.02e-05	4	128	2	23351466
Pubmed	CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration.	ELMO1 ELMO3	8.02e-05	4	128	2	11595183
Pubmed	G-protein coupled receptor BAI3 promotes myoblast fusion in vertebrates.	ELMO1 ELMO3	8.02e-05	4	128	2	24567399
Pubmed	Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle.	MYH1 MYH4	8.02e-05	4	128	2	11029314
Pubmed	LC3/GABARAPs drive ubiquitin-independent recruitment of Optineurin and NDP52 to amplify mitophagy.	CALCOCO2 OPTN	8.02e-05	4	128	2	30679426
Pubmed	Loss of β2-spectrin prevents cardiomyocyte differentiation and heart development.	SPTBN1 DMD	8.02e-05	4	128	2	24064296
Pubmed	Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling.	MYH1 MYH4	8.02e-05	4	128	2	18417546
Interaction	ATG16L1 interactions	CALCOCO2 BICD2 TFEB GRIPAP1 CNTRL EIF3E NAP1L1 ZNF622 TRIP11 ELMO1 TAOK3 OPTN PABPN1 ANLN CEP95 GCC2 BTF3 EIF4G2 HSD17B12 KIF14 AKAP13 KATNIP TAF7 NBR1 GOLGB1 IPO11 RGPD5	2.88e-09	1161	127	27	int:ATG16L1
Interaction	HERC2 interactions	PMS1 BICD2 CEP162 SPTBN1 EIF3E ZNF622 RGS12 DST AKAP9 GCC2 BTF3 SYNE2 HSD17B12 TAF4 TOP3B CCDC136 IPO11	1.84e-08	503	127	17	int:HERC2
Interaction	SYCE1 interactions	BICD2 CENPF CNTRL RAD50 AKAP9 EEA1 GOLGA1 CCDC136 GOLGA4	1.12e-07	127	127	9	int:SYCE1
Interaction	PCNT interactions	CEP162 SPTBN1 CNTRL TRIP11 DST AKAP9 KIF14 NAA40 EIF4G3 TOP3B GOLGA1	3.74e-07	241	127	11	int:PCNT
Interaction	MYCBP2 interactions	EPHB2 RGPD8 SPTBN1 PCDHB6 RGS12 DST PABPN1 SYNE2 CTNNA3 KIF14 EEA1 TOP3B NBR1	3.94e-07	355	127	13	int:MYCBP2
Interaction	EIF4A1 interactions	CALCOCO2 EIF3E PRPF8 PLPPR4 ANLN BTF3 EIF4G2 KIF14 ANO7 EIF4G3 TOP3B NBR1 IPO11	3.94e-07	355	127	13	int:EIF4A1
Interaction	CEP55 interactions	CALCOCO2 BICD2 CEP162 VPS37B AKAP9 ANLN BTF3 FER KIF14 NBR1 GOLGA1	6.81e-07	256	127	11	int:CEP55
Interaction	NAP1L4 interactions	BICD2 EIF3E NAP1L1 PRPF8 CUL5 ANLN BTF3 KIF14 NAA40 TAF4	7.41e-07	206	127	10	int:NAP1L4
Interaction	BRK1 interactions	EPHB2 GRIPAP1 CENPF TRIP11 AKAP9 GCC2 EEA1 EPHA5	1.19e-06	124	127	8	int:BRK1
Interaction	EIF4A2 interactions	PIH1D2 EIF3E OPTN ANLN EIF4G2 KIF14 EIF4G3 TOP3B IPO11	1.39e-06	171	127	9	int:EIF4A2
Interaction	ARHGAP21 interactions	CNTRL PABPN1 ANLN SYNE2 RASGEF1B FER AFDN AKAP13 NAA40 TOP3B	1.52e-06	223	127	10	int:ARHGAP21
Interaction	FBXO22 interactions	CENPF SPTBN1 PCDHB6 COPS3 PRPF8 RGS12 KMT2C VPS13D TAOK3 GTF3C1 PLCB4 TAF4 TOP3B GOLGA1 IPO11	1.61e-06	540	127	15	int:FBXO22
Interaction	MLLT6 interactions	GRIPAP1 RGPD8 GCC2 AFDN EEA1 TOP3B RGPD5	2.33e-06	95	127	7	int:MLLT6
Interaction	SEPTIN10 interactions	EPHB2 CENPF TRIP11 AKAP9 ANLN GCC2 GOLGB1 EPHA5	3.66e-06	144	127	8	int:SEPTIN10
Interaction	KIAA1671 interactions	CALCOCO2 BICD2 CEP162 CNTRL ANLN KIF14 AFDN NAA40 GOLGA1	3.93e-06	194	127	9	int:KIAA1671
Interaction	PFN1 interactions	CALCOCO2 SPTBN1 TRIP11 AKAP9 ANLN GCC2 BTF3 SYNE2 KIF14 AFDN AKAP13 NAA40 GOLGA4 GOLGB1	4.10e-06	509	127	14	int:PFN1
Interaction	NDC80 interactions	BICD2 EFL1 CEP162 RAD50 AKAP9 CEP95 GCC2 SYNE2 KIF14 TOP3B CCDC136	4.64e-06	312	127	11	int:NDC80
Interaction	YWHAH interactions	TFEB CEP162 SPTBN1 CNTRL TRIP11 RGS12 VPS13D OPTN DST AKAP9 PIK3CA ANLN CEP95 BTF3 SYNE2 KIF14 AFDN AKAP13 EIF4G3 SUCO GOLGA4	5.20e-06	1102	127	21	int:YWHAH
Interaction	YWHAB interactions	TFEB CEP162 SPTBN1 TRIP11 RGS12 RAD50 VPS13D OPTN DST AKAP9 ANLN CEP95 GCC2 BTF3 FER KIF14 AFDN AKAP13 NAA40 SUCO	5.40e-06	1014	127	20	int:YWHAB
Interaction	TMOD1 interactions	COPS3 PIK3CA ANLN GCC2 KIF14 NAA40 GOLGA4 GOLGB1	8.35e-06	161	127	8	int:TMOD1
Interaction	NUP62 interactions	BICD2 RGPD8 CCDC150 SOX13 CUL5 ANLN SYNE2 NAA40 FUBP3 RGPD5	9.18e-06	273	127	10	int:NUP62
Interaction	FASN interactions	CALCOCO2 EFL1 ZNF622 HSPBP1 PRPF8 CUL5 KMT2C PIK3CA ANLN BTF3 HSD17B12 KIF14 ANO7 NAA40 ATP13A3 MAML2 GFPT2 TAF4 TOP3B NBR1	1.07e-05	1062	127	20	int:FASN
Interaction	IPO5 interactions	CALCOCO2 PMS1 CEP162 NAP1L1 PRPF8 RAD50 AKAP9 HSD17B12 KIF14 TOP3B NBR1 GOLGA4	1.23e-05	414	127	12	int:IPO5
Interaction	GBP7 interactions	GBP7 SYNE2 GOLGA4	1.34e-05	8	127	3	int:GBP7
Interaction	MKI67 interactions	ZNF384 CENPF PRPF8 CUL5 OPTN DST GTF3C1 ANLN BTF3 KIF14 AKAP13 NAA40 TFB2M FUBP3 NBR1	1.44e-05	648	127	15	int:MKI67
Interaction	IFITM1 interactions	GRIPAP1 SPART TRIP11 MTMR6 GCC2 HSD17B12 EEA1 FAR1 NBR1 GOLGA4 GOLGB1	1.56e-05	355	127	11	int:IFITM1
Interaction	PCM1 interactions	BICD2 CEP162 CNTRL FAM81A AKAP9 CEP95 GCC2 BTF3 KIF14 NAA40 EEA1 GOLGA1	1.97e-05	434	127	12	int:PCM1
Interaction	DYNLL1 interactions	DYNC2H1 COPS3 PRPF8 RAD50 KMT2C OPTN AKAP9 ANLN BTF3 KIF14 NAA40 CCDC136 GOLGB1	2.06e-05	510	127	13	int:DYNLL1
Interaction	PCBP1 interactions	BICD2 ZNF384 EIF3E ZNF622 PRPF8 CUL5 PIK3CA ANLN BTF3 EIF4G2 KIF14 ANO7 NAA40 FUBP3 NBR1	2.17e-05	671	127	15	int:PCBP1
Interaction	KRT8 interactions	BICD2 MYH1 GRIPAP1 CEP162 PRPF8 TRIP11 AKAP9 ANLN BTF3 KIF14 DMD NBR1	2.31e-05	441	127	12	int:KRT8
Interaction	ERC1 interactions	BICD2 CEP162 CNTRL ANLN KIF14 NAA40 EEA1 GOLGA1	2.48e-05	187	127	8	int:ERC1
Interaction	BIRC3 interactions	CALCOCO2 KIF27 CENPF DYNC2H1 SPTBN1 EIF3E NAP1L1 CASP10 COPS3 HSPBP1 PRPF8 RAD50 GTF3C1 PABPN1 EIF4G2 HSD17B12 AFDN EEA1 FAR1 FUBP3 NBR1 GOLGA4	2.90e-05	1334	127	22	int:BIRC3
Interaction	TNIK interactions	EPHB2 CALCOCO2 BICD2 CENPF SPTBN1 DST AKAP9 SYNE2 NAA40 GOLGA4 EPHA5	2.99e-05	381	127	11	int:TNIK
Interaction	PHGDH interactions	CALCOCO2 PRPF8 CUL5 GTF3C1 ANLN BTF3 KIF14 ANO7 NAA40 TOP3B NBR1	3.29e-05	385	127	11	int:PHGDH
Interaction	YWHAG interactions	CALCOCO2 TFEB CEP162 SPTBN1 TRIP11 RGS12 VPS13D OPTN DST AKAP9 ANLN CEP95 GCC2 BTF3 SYNE2 KIF14 AFDN AKAP13 EIF4G3 SUCO NBR1	3.38e-05	1248	127	21	int:YWHAG
Interaction	CEP170 interactions	CEP162 CNTRL MTMR6 AKAP9 ANLN BTF3 SYNE2 KIF14 NAA40 CCDC136	3.41e-05	318	127	10	int:CEP170
Interaction	CHN2 interactions	CUL5 SYNE2 RASGEF1B AKAP13 PLCL1 DMD	3.44e-05	97	127	6	int:CHN2
Interaction	TRRAP interactions	PMS1 DYNC2H1 SPTBN1 CNTRL EIF3E ZNF622 CASP10 RAD50 RHOBTB1 KIF14 TFB2M TAF4 DMD TAF7 TOP3B NBR1	3.76e-05	790	127	16	int:TRRAP
Interaction	ARHGAP42 interactions	PABPN1 BTF3 SYNE2 RASGEF1B AKAP13	3.80e-05	60	127	5	int:ARHGAP42
Interaction	CALM1 interactions	IQCN VPS13D OPTN DST PPP3R1 AKAP9 PIK3CA ANLN BTF3 SYNE2 FER KIF14 NAA40 NBR1	4.13e-05	626	127	14	int:CALM1
Interaction	ABTB2 interactions	MYH1 MYH4 PGK2 IFT88 KIF14 TOP3B	4.32e-05	101	127	6	int:ABTB2
Interaction	VIM interactions	CALCOCO2 BICD2 UBR1 ZNF384 ANGPT2 CNTRL SPART HSPBP1 PRPF8 VPS13D RHOBTB1 ANLN BTF3 KIF14 NAA40 GOLGA4	4.64e-05	804	127	16	int:VIM
Interaction	NUP155 interactions	CALCOCO2 PRPF8 TRIP11 VPS13D ANLN GCC2 SYNE2 KIF14 GOLGA4 GOLGB1 IPO11 EPHA5	4.94e-05	477	127	12	int:NUP155
Interaction	PDLIM5 interactions	BICD2 SPTBN1 SYNE2 RASGEF1B AKAP13 NAA40 DMD CCDC136 IPO11	5.93e-05	273	127	9	int:PDLIM5
Interaction	C2CD3 interactions	BICD2 CEP162 CNTRL TOP3B	6.02e-05	34	127	4	int:C2CD3
Interaction	HNRNPCL2 interactions	PMS1 DYNC2H1 PRPF8 TRIP11 RAD50 AKAP9 ANLN KIF14 NAA40	6.10e-05	274	127	9	int:HNRNPCL2
Interaction	CCT8L2 interactions	PMS1 GRIPAP1 DYNC2H1 TRIP11 RAD50 EIF4G3 RGPD5	6.23e-05	157	127	7	int:CCT8L2
Interaction	PHF21A interactions	BICD2 GRIPAP1 CENPF RAD50 DST GCC2 KIF14 NAA40 FAR1 GOLGB1	6.43e-05	343	127	10	int:PHF21A
Interaction	DYNC1H1 interactions	CALCOCO2 BICD2 CNTRL SPART PRPF8 RAD50 OPTN ANLN BTF3 KIF14 TOP3B NBR1	6.52e-05	491	127	12	int:DYNC1H1
Interaction	DBN1 interactions	CALCOCO2 CEP162 SPTBN1 NAP1L1 DST RHOBTB1 ANLN BTF3 KIF14 AFDN NAA40	6.77e-05	417	127	11	int:DBN1
Interaction	PPP1R7 interactions	CALCOCO2 BICD2 HSPBP1 RAD50 OPTN FER	7.34e-05	111	127	6	int:PPP1R7
Interaction	ARF4 interactions	CALCOCO2 CEP162 COPS3 TRIP11 ANLN BTF3 KIF14 FUBP3 NBR1	7.40e-05	281	127	9	int:ARF4
Interaction	YWHAZ interactions	TFEB CEP162 SPTBN1 PRPF8 RGS12 VPS13D OPTN DST AKAP9 ANLN CEP95 GCC2 BTF3 SYNE2 CTNNA3 KIF14 AFDN AKAP13 KATNIP NAA40 SUCO	7.50e-05	1319	127	21	int:YWHAZ
Interaction	CSDE1 interactions	BICD2 RAD50 ANLN BTF3 KIF14 NAA40 FUBP3 TOP3B NBR1	8.02e-05	284	127	9	int:CSDE1
Interaction	LIMA1 interactions	SPTBN1 PRPF8 DST ANLN BTF3 FER KIF14 AFDN NAA40 EIF4G3 TOP3B	8.71e-05	429	127	11	int:LIMA1
Interaction	TJP2 interactions	BICD2 CNTRL CFAP141 MTMR6 ANLN BTF3 EIF4G2 KIF14 AFDN	8.93e-05	288	127	9	int:TJP2
Interaction	PKP2 interactions	GRIPAP1 AKAP9 ANLN BTF3 KIF14 AFDN TOP3B EPHA5	9.14e-05	225	127	8	int:PKP2
Interaction	TNKS1BP1 interactions	SPTBN1 ANLN BTF3 KIF14 NAA40 TOP3B GOLGA1	9.53e-05	168	127	7	int:TNKS1BP1
Interaction	RBM33 interactions	PRPF8 PABPN1 KIF14 EEA1 FUBP3 TOP3B	9.83e-05	117	127	6	int:RBM33
Interaction	RPS20 interactions	EIF3E PRPF8 RAD50 CUL5 PIK3CA ANLN BTF3 EIF4G2 KIF14 NAA40 FUBP3 TOP3B	9.87e-05	513	127	12	int:RPS20
Interaction	RAB9A interactions	GRIPAP1 CNTRL TRIP11 MTMR6 VPS13D OPTN DST GCC2 SYNE2 ATP13A3 EEA1 GOLGA4 GOLGB1	9.96e-05	595	127	13	int:RAB9A
Interaction	SIPA1L3 interactions	BICD2 ANLN BTF3 KIF14 AFDN TOP3B	1.03e-04	118	127	6	int:SIPA1L3
Interaction	DSCAM interactions	SPTBN1 PIH1D2 PRPF8 TRIP11 DST IFT88 AFDN	1.06e-04	171	127	7	int:DSCAM
Interaction	EIF6 interactions	EFL1 SPTBN1 ZNF622 PRPF8 PABPN1 ANLN KIF14 ANO7 NAA40 TOP3B	1.07e-04	365	127	10	int:EIF6
Interaction	WHAMMP3 interactions	BICD2 CNTRL AKAP9 CEP95 GCC2 GOLGA1	1.08e-04	119	127	6	int:WHAMMP3
Interaction	ARHGAP26 interactions	SYNE2 RASGEF1B AKAP13 DMD TOP3B GOLGA4	1.13e-04	120	127	6	int:ARHGAP26
Interaction	PRPF18 interactions	CALCOCO2 BICD2 GRIPAP1 CCDC150 PRPF8 CCDC136	1.13e-04	120	127	6	int:PRPF18
Interaction	KCNA3 interactions	SPTBN1 SPART RAD50 KMT2C DST CEP95 EIF4G2 CTNNA3 HSD17B12 AFDN CARD11 FAR1 TAF7 EIF4G3 GOLGA4 GOLGB1	1.18e-04	871	127	16	int:KCNA3
Interaction	HSPA1B interactions	EPHB2 CALCOCO2 CNTRL HSPBP1 CUL5 FAM83F ANLN BTF3 EPHA5	1.25e-04	301	127	9	int:HSPA1B
Interaction	DR1 interactions	CEP162 SPTBN1 COPS3 BTF3 IPO11	1.26e-04	77	127	5	int:DR1
Interaction	TXLNA interactions	CENPF CEP162 CNTRL FAM81A DST ANLN BTF3 CCDC136	1.27e-04	236	127	8	int:TXLNA
Interaction	GNAT3 interactions	ANLN SYNE2 KIF14	1.29e-04	16	127	3	int:GNAT3
Interaction	MAP7D3 interactions	CALCOCO2 CEP162 CNTRL ANLN KIF14 NAA40	1.29e-04	123	127	6	int:MAP7D3
Interaction	POLDIP3 interactions	EPHB2 BICD2 UBR1 ANLN EIF4G2 NAA40 TOP3B EPHA5	1.31e-04	237	127	8	int:POLDIP3
Interaction	DUSP16 interactions	PMS1 DYNC2H1 SKA2 PRPF8 TRIP11 TOP3B NBR1 RGPD5	1.31e-04	237	127	8	int:DUSP16
Interaction	PRPF31 interactions	CALCOCO2 BICD2 EIF3E ZNF622 PRPF8 RHOBTB1 ANLN KIF14 TAF7 CCDC136	1.31e-04	374	127	10	int:PRPF31
Interaction	CCDC85C interactions	BICD2 CNTRL IQCN AFDN NAA40 CCDC136	1.41e-04	125	127	6	int:CCDC85C
Interaction	LCA5 interactions	CEP162 NAP1L1 ZNF622 COPS3 IFT88 KIF14	1.41e-04	125	127	6	int:LCA5
Interaction	GNAI3 interactions	RGS12 OPTN PIK3CA ANLN SYNE2 KIF14 TOP3B NBR1	1.47e-04	241	127	8	int:GNAI3
Interaction	RAB4A interactions	GRIPAP1 TRIP11 MTMR6 VPS13D DST GCC2 SYNE2 ATP13A3 EEA1 GOLGA4 GOLGB1	1.52e-04	457	127	11	int:RAB4A
Interaction	EIF3M interactions	EIF3E NAP1L1 PRPF8 OPTN GTF3C1 ANLN EIF4G3	1.57e-04	182	127	7	int:EIF3M
Interaction	CFL1 interactions	CALCOCO2 PRPF8 DST ANLN BTF3 KIF14 NAA40 FUBP3 TOP3B NBR1	1.62e-04	384	127	10	int:CFL1
Interaction	YTHDF2 interactions	ANLN EIF4G2 KIF14 NAA40 TAF4 EIF4G3 FUBP3 TOP3B NBR1	1.63e-04	312	127	9	int:YTHDF2
Interaction	FBXO32 interactions	BICD2 MYH1 MYH4 EIF3E COPS3 HSPBP1 GTF3C1 PIK3CA AFDN FUBP3	1.69e-04	386	127	10	int:FBXO32
Interaction	SDC4 interactions	CALCOCO2 OPTN GTF3C1 ANLN NBR1	1.70e-04	82	127	5	int:SDC4
Interaction	RHOA interactions	SPTBN1 CASP10 TRIP11 VPS13D OPTN ANLN SYNE2 HSD17B12 KIF14 AKAP13 PLCB4 ATP13A3 TAF7 FUBP3 TOP3B NBR1 GOLGA4 GOLGB1 IPO11	1.82e-04	1199	127	19	int:RHOA
Interaction	ARL4A interactions	ELMO1 ELMO3 GCC2	1.86e-04	18	127	3	int:ARL4A
Interaction	NPIPB6 interactions	RGPD8 KIF14 RGPD5	1.86e-04	18	127	3	int:NPIPB6
Interaction	RGPD3 interactions	RGPD8 BTF3 KIF14 RGPD5	2.18e-04	47	127	4	int:RGPD3
Interaction	ROCK1 interactions	EPHB2 EFL1 TAOK3 RHOBTB1 ANLN AFDN TAF4	2.18e-04	192	127	7	int:ROCK1
Interaction	NOLC1 interactions	AKAP9 GTF3C1 ANLN FAM186A KIF14 ANO7 NAA40 POLK GOLGA4	2.21e-04	325	127	9	int:NOLC1
Interaction	YWHAQ interactions	TFEB CEP162 PRPF8 TRIP11 RGS12 VPS13D OPTN DST PABPN1 ANLN CEP95 BTF3 KIF14 AFDN AKAP13 NAA40 SUCO GOLGB1	2.26e-04	1118	127	18	int:YWHAQ
Interaction	CDC42 interactions	CALCOCO2 PMS1 UBR1 DYNC2H1 SPTBN1 ZNF622 TRIP11 TAOK3 ANLN BTF3 SYNE2 HSD17B12 KIF14 AFDN PLCB4 ATP13A3 TAF7 GOLGB1 IPO11 EPHA5	2.27e-04	1323	127	20	int:CDC42
Interaction	TSNAX interactions	GRIPAP1 RGPD8 AKAP9 KIF14 NAA40 TOP3B RGPD5	2.32e-04	194	127	7	int:TSNAX
Interaction	LUZP1 interactions	BICD2 CEP162 CNTRL CUL5 ANLN BTF3 KIF14	2.32e-04	194	127	7	int:LUZP1
Interaction	FBXO42 interactions	TFEB GRIPAP1 RGPD8 SPART COPS3 TRIP11 KIF14 GOLGB1	2.40e-04	259	127	8	int:FBXO42
Interaction	MSN interactions	EPHB2 CNTRL NAP1L1 CASP10 PGK2 RAD50 ANLN KIF14 GOLGB1	2.48e-04	330	127	9	int:MSN
Interaction	RAB2A interactions	EPHB2 CALCOCO2 SPTBN1 CNTRL TRIP11 ANLN GCC2 HSD17B12 KIF14 ATP13A3 GOLGA4 GOLGB1	2.49e-04	567	127	12	int:RAB2A
Interaction	CLTC interactions	CALCOCO2 SPTBN1 CNTRL SPART PRPF8 CUL5 OPTN RHOBTB1 PIK3CA ANLN BTF3 KIF14 NBR1	2.56e-04	655	127	13	int:CLTC
Interaction	RGPD1 interactions	BICD2 RGPD8 GOLGA1 RGPD5	2.56e-04	49	127	4	int:RGPD1
GeneFamily	Engulfment and cell motility proteins	ELMO1 ELMO3	4.68e-05	3	72	2	543
GeneFamily	Fibronectin type III domain containing\|Sterile alpha motif domain containing\|EPH receptors	EPHB2 EPHA5	1.38e-03	14	72	2	1095
GeneFamily	Myosin heavy chains	MYH1 MYH4	1.59e-03	15	72	2	1098
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	DMD NBR1	2.30e-03	18	72	2	91
GeneFamily	Phospholipases\|C2 domain containing phospholipases	PLCB4 PLCL1	2.56e-03	19	72	2	832
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	RUBCNL EIF3E NAP1L1 TRIP11 RAD50 TAOK3 OPTN PIK3CA ANLN GCC2 SYNE2 FER KIF14 EEA1 POLK SUCO GOLGA4 GOLGB1	3.03e-09	656	127	18	M18979
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	EPHB2 PMS1 CENPF SPART TAOK3 DST PPP3R1 AKAP9 GCC2 SYNE2 KIF14 AKAP13 PLCB4 ATP13A3 TAF4 DMD EIF4G3 SUCO GOLGA4	3.24e-08	856	127	19	M4500
Coexpression	MURARO_PANCREAS_BETA_CELL	EIF3E NAP1L1 PRPF8 TRIP11 ELMO1 RAD50 KMT2C MTMR6 DST GTF3C1 GCC2 SYNE2 PLCB4 EIF4G3 SUCO GOLGA4 GOLGB1	3.33e-06	946	127	17	M39169
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	PMS1 EFL1 CENPF DYNC2H1 SKA2 RAD50 CUL5 KMT2C PIK3CA ANLN EIF4G2 KIF14 ATP13A3 FAR1	1.11e-05	721	127	14	M10237
Coexpression	HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_1DY_DN	REX1BD TCN1 RUBCNL SYCP2 NAA40	1.38e-05	63	127	5	M41106
Coexpression	BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP	CENPF KIF14 CCDC144A	2.37e-05	12	127	3	M34000
Coexpression	GHO_ATF5_TARGETS_UP	RHOBTB1 IFT88 EIF4G2	3.07e-05	13	127	3	M12008
Coexpression	MATZUK_MEIOTIC_AND_DNA_REPAIR	SYCP3 SYCP2 PPP3R1 TOP3B	3.79e-05	39	127	4	M1819
Coexpression	GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN	DYNC2H1 PCDHB6 MTMR6 AKAP9 RASGEF1B EEA1 FNDC8	4.18e-05	191	127	7	M4922
Coexpression	GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	UBR1 GBP7 VPS37B TRIP11 VPS13D RASGEF1B CARD11	5.59e-05	200	127	7	M6035
Coexpression	ZHAN_MULTIPLE_MYELOMA_PR_DN	TFEB SYNE2 PLCL1 RGPD5	9.41e-05	49	127	4	M10412
Coexpression	ZHENG_CORD_BLOOD_C7_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_1	CALCOCO2 SPTBN1 NAP1L1 TAOK3 BTF3	1.06e-04	96	127	5	M39216
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	PMS1 CENPF MTMR6 DST AKAP9 KIF14 ATP13A3 SUCO	1.11e-04	300	127	8	M8702
Coexpression	LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES	DST CTNNA3 FER AKAP13 PLCL1 DMD	1.11e-04	155	127	6	M39246
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	CENPF CEP162 CNTRL TRIP11 RAD50 VPS13D AKAP9 GCC2 SYNE2 HSD17B12 GOLGA4 GOLGB1	5.73e-13	198	128	12	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	CEP162 CNTRL TRIP11 RAD50 VPS13D AKAP9 GCC2 SYNE2 HSD17B12 EEA1 GOLGA4 GOLGB1	6.08e-13	199	128	12	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	BICD2 TRIP11 RAD50 AKAP9 GCC2 SYNE2 HSD17B12 EEA1 EIF4G3 GOLGA4 GOLGB1	1.49e-11	199	128	11	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	NAP1L1 TRIP11 RAD50 DST AKAP9 GCC2 SYNE2 HSD17B12 EEA1 GOLGA4 GOLGB1	1.49e-11	199	128	11	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	CNTRL TRIP11 RAD50 AKAP9 GCC2 SYNE2 HSD17B12 EEA1 GOLGA4 GOLGB1	3.29e-10	199	128	10	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	TRIP11 RAD50 AKAP9 GCC2 SYNE2 HSD17B12 EEA1 GOLGA4 GOLGB1	6.54e-09	199	128	9	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	TRIP11 RAD50 AKAP9 GCC2 SYNE2 HSD17B12 EEA1 GOLGA4 GOLGB1	6.54e-09	199	128	9	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	EIF3E NAP1L1 AKAP9 GCC2 FER AFDN GOLGA4 GOLGB1	9.13e-08	193	128	8	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	TRIP11 RAD50 AKAP9 GCC2 SYNE2 EEA1 GOLGA4 GOLGB1	1.16e-07	199	128	8	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	TRIP11 RAD50 AKAP9 GCC2 SYNE2 EEA1 GOLGA4 GOLGB1	1.16e-07	199	128	8	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	ASK428-Immune-Mast_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	EIF3E CCDC150 SYCP3 SOX13 FAM83F FER GPAT2	5.77e-07	168	128	7	c399fcb4d1d0be48026c2ecabc34a5935e7adf73
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBP7 CNTRL TRIP11 AKAP9 SYNE2 PLCB4 TAF7	8.52e-07	178	128	7	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN1 CNTRL TRIP11 GCC2 TAF7 EIF4G3 GOLGA4	1.06e-06	184	128	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	ANGPT2 CASP10 SOX13 ELMO1 SYNE2 HSD17B12 PLCB4	1.18e-06	187	128	7	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	SLC25A33 RHOBTB1 SYNE2 AFDN AKAP13 GOLGA4 GOLGB1	1.27e-06	189	128	7	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPTBN1 DST AKAP9 EIF4G2 AFDN GOLGA4 GOLGB1	1.32e-06	190	128	7	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RGPD8 ELMO1 KMT2C AKAP13 ATP13A3 MAML2 EIF4G3	1.46e-06	193	128	7	779276e775cb2492e8dd36436295a536084a6415
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DYNC2H1 TRIP11 KMT2C DST AKAP9 GOLGA4 GOLGB1	1.57e-06	195	128	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	RAD50 KMT2C TAOK3 GTF3C1 PABPN1 AKAP13 GOLGB1	1.62e-06	196	128	7	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	mild-CD4+_T_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SPTBN1 EIF3E NAP1L1 GCC2 SYNE2 PLCL1 MAML2	1.79e-06	199	128	7	3e4baaf4ee23f257d821194468102c00a8ad2f21
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	KMT2C RASGEF1B FER PLCB4 MAML2 DMD EIF4G3	1.79e-06	199	128	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SPTBN1 CASP10 KMT2C DST SYNE2 AFDN PLCB4	1.85e-06	200	128	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	ANGPT2 GBP7 SPTBN1 CASP10 OPTN SYNE2 AFDN	1.85e-06	200	128	7	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KMT2C AKAP9 SYNE2 RASGEF1B AKAP13 GOLGA4 GOLGB1	1.85e-06	200	128	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	TRIP11 RAD50 AKAP9 GCC2 SYNE2 GOLGB1	2.98e-06	138	128	6	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	ASK428-Immune-Mast_cell\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	EIF3E CCDC150 SOX13 FAM83F FER GPAT2	7.76e-06	163	128	6	569ca0e8ce307f258910b0c75c498009a9651e6e
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBP7 SPTBN1 SYNE2 AFDN PLCB4 TAF7	1.24e-05	177	128	6	ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBP7 SPTBN1 SYNE2 AFDN PLCB4 TAF7	1.24e-05	177	128	6	f471f7747d6e8db7546899019af9508f48a14f89
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBP7 SPTBN1 SYNE2 AFDN PLCB4 TAF7	1.24e-05	177	128	6	cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANGPT2 SOX13 ELMO1 SYNE2 HSD17B12 PLCB4	1.32e-05	179	128	6	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HK3 CENPF SKA2 ANLN KIF14 ATP13A3	1.45e-05	182	128	6	21dcab170ffeef89faa9fee5008568cb6e15c694
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T\|lymph-node_spleen / Manually curated celltypes from each tissue	CASP10 RGS12 DST ANLN FAR1 GPAT2	1.64e-05	186	128	6	17eec1efad1f5e9ced1eb6bc9eb5dd7ded789c61
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRIP11 AKAP9 SYNE2 FAR1 GOLGA4 GOLGB1	1.69e-05	187	128	6	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ELMO1 DST AKAP9 GCC2 AKAP13 GOLGB1	1.69e-05	187	128	6	0099def970fbc828756fbf853eca2ce77b8cd342
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	AKAP9 SYNE2 RASGEF1B GFPT2 GOLGB1 RGPD5	1.80e-05	189	128	6	2c8a2fb76ea002bac554bc1c761ce960b5e116e1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FAM81A SLC9C1 FAM83F FER AFDN CARD11	1.91e-05	191	128	6	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN1 CNTRL TRIP11 CUL5 SYNE2 GOLGB1	1.91e-05	191	128	6	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANGPT2 GBP7 SPTBN1 CASP10 AFDN PLCB4	1.91e-05	191	128	6	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN1 CNTRL TRIP11 CUL5 SYNE2 GOLGA4	1.91e-05	191	128	6	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN1 CNTRL TRIP11 CUL5 SYNE2 GOLGB1	1.91e-05	191	128	6	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	RHOBTB1 SYNE2 AKAP13 PLCL1 MAML2 GOLGA4	1.97e-05	192	128	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	Severe_COVID-19-Myeloid-proliferating_Myeloid_cells\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	CENPF SKA2 DST ANLN KIF14 GPAT2	2.03e-05	193	128	6	0d85025690c9cd545cba30abc38acbdd6a39b153
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPF SKA2 DST ANLN KIF14 GPAT2	2.09e-05	194	128	6	cb39850e9577015b6b9834e98c36b412bae7d462
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPF SKA2 DST ANLN KIF14 GPAT2	2.09e-05	194	128	6	408597c9aa302a44b112c1d612c21fbb0227a82a
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CENPF SKA2 DST ANLN KIF14 GPAT2	2.09e-05	194	128	6	193cc20fefbd795a4ad59e401a95af47d30603e7
ToppCell	BAL-Severe-Myeloid-Myeloid\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPF SKA2 DST ANLN KIF14 GPAT2	2.09e-05	194	128	6	2360b5f995b360419de41612368cab9fb61781a1
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CENPF SKA2 DST ANLN KIF14 GPAT2	2.09e-05	194	128	6	903ae11708b0cb24538c6982abd57fe6fa95b8d3
ToppCell	BAL-Severe-Myeloid-Myeloid\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CENPF SKA2 DST ANLN KIF14 GPAT2	2.09e-05	194	128	6	58406502a8cbcc3037f79a1b6a683df408297ae5
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DYNC2H1 KMT2C DST AKAP9 GOLGA4 GOLGB1	2.15e-05	195	128	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Mild\|World / Condition, Lineage, Cell class and cell subclass	REX1BD RAD50 DST AKAP9 GCC2 GOLGB1	2.27e-05	197	128	6	476b0d0389f9fcd4614f6bb1f494281f467f6730
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CENPF SPTBN1 CNTRL SKA2 ANLN KIF14	2.34e-05	198	128	6	c3dd887c95587f930b7afd32385627a9fa029ca4
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Otof_(eccentric_SPN,_iSPN-like_markers)\|Striatum / BrainAtlas - Mouse McCarroll V32	SCNN1G CARD11 GPAT2 SLFNL1	2.35e-05	58	128	4	af702c318fc970707660e5d0cfb7b08df3a6e809
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Otof_(eccentric_SPN,_iSPN-like_markers)-\|Striatum / BrainAtlas - Mouse McCarroll V32	SCNN1G CARD11 GPAT2 SLFNL1	2.35e-05	58	128	4	538f572db2f34b71058cf09d2db374a906f53580
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CENPF RUBCNL CNTRL SKA2 ANLN KIF14	2.41e-05	199	128	6	c9d15c84b9f8c87b4ea0008be7d5efc5f45efd1a
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-FOXM1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CENPF CNTRL CCDC150 ANLN SYNE2 KIF14	2.41e-05	199	128	6	98575fcce726589e93fbb4df1aab03e57cb56076
ToppCell	LPS_IL1RA-Endothelial-Endothelial-FOXM1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CENPF CNTRL CCDC150 ANLN SYNE2 KIF14	2.41e-05	199	128	6	be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SPTBN1 DST AKAP9 SYNE2 AFDN GOLGB1	2.47e-05	200	128	6	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	ANGPT2 GBP7 SPTBN1 CASP10 OPTN AFDN	2.47e-05	200	128	6	6f531a418ff25b59a543800cf4bce7b72404ce08
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ANGPT2 SPTBN1 CASP10 OPTN EIF4G2 AFDN	2.47e-05	200	128	6	2d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Artery\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SOX13 DST SYNE2 AFDN PLCB4 ATP13A3	2.47e-05	200	128	6	77ae679c35d3b9e2b620f34129f3a8d47e922c65
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SPTBN1 CASP10 DST SYNE2 AFDN PLCB4	2.47e-05	200	128	6	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SOX13 DST SYNE2 AFDN PLCB4 ATP13A3	2.47e-05	200	128	6	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	AKAP9 SYNE2 AKAP13 GOLGA4 GOLGB1	4.44e-05	135	128	5	ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RUBCNL ELMO1 DST AKAP13 GOLGB1	4.44e-05	135	128	5	b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1\|Striatum / BrainAtlas - Mouse McCarroll V32	KIF27 ISL1 PPP3R1 AKAP9 GPAT2	6.45e-05	146	128	5	7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCDC110 PIH1D2 CCDC150 FAM81A PLPPR4	7.56e-05	151	128	5	e335dad89e0a44cdd302b9653154ba5d1ee5fe1a
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCDC110 PIH1D2 CCDC150 FAM81A PLPPR4	7.56e-05	151	128	5	633ed52dd3b4cf1e87432cf0a1ca187d7b204e83
ToppCell	368C-Fibroblasts-Fibroblast-H\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	PMS1 BICD2 GBP7 ZFAND4 NAA40	8.30e-05	154	128	5	f29316d4b4dcdb23bd427d78068e65a9802f7f07
ToppCell	368C-Fibroblasts-Fibroblast-H-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	PMS1 BICD2 GBP7 ZFAND4 NAA40	8.30e-05	154	128	5	66065c0763c83d98084ca6969694c3af37e43274
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4\|TCGA-Colorectal / Sample_Type by Project: Shred V9	GRIPAP1 CENPF CCDC150 PABPN1 TAF4	1.18e-04	166	128	5	52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b
ToppCell	Control-B_intermediate-1\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	REX1BD RUBCNL SPART RAD50 AFDN	1.21e-04	167	128	5	948504367ecf58144d9dd74d2ec531358fc4b309
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFL1 VPS37B SYCP2 CARD11 POLK	1.25e-04	168	128	5	182f08106ac65ea501e2fb9139d3b44b7c4662c9
ToppCell	Dividing_Macrophages-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	CENPF SKA2 ANLN KIF14 PMFBP1	1.28e-04	169	128	5	eb0c993ef2eea73bc4881182520922ce9ae9368f
ToppCell	droplet-Marrow-nan-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBP7 TRIP11 GTF3C1 MAML2 EEA1	1.28e-04	169	128	5	5f5bec13208f4c3b6eacbba180c8a6402743b76e
ToppCell	droplet-Kidney-KIDNEY-1m-Myeloid-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BICD2 TFEB EFL1 ANLN CEP95	1.36e-04	171	128	5	d9ad6a3bce3556abd24af1630bf4a99594437c3a
ToppCell	Control-B_naive-1\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	REX1BD EFL1 RUBCNL SPTBN1 SPART	1.36e-04	171	128	5	d18855b24aadea38fd1e4592f945cf15b85e05f1
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-B_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RUBCNL ELMO3 RAVER2 AFDN SHCBP1L	1.43e-04	173	128	5	0a0cd40bb5f61431fe34758626c8a63ec610a8a5
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPF CCDC150 ANLN SYNE2 KIF14	1.47e-04	174	128	5	94575a605c725de83f66a6cf7df9d7bb360ffc56
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPF CCDC150 ANLN SYNE2 KIF14	1.47e-04	174	128	5	40c81ab36d7931e271e20d7d56fed32463c75f41
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CNTRL ZFAND4 ANLN CARD11 GPAT2	1.47e-04	174	128	5	9bb8159a62640756d18ecbade3bf32bcbb7dd590
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPF CCDC150 ANLN SYNE2 KIF14	1.47e-04	174	128	5	b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CNTRL ZFAND4 ANLN CARD11 GPAT2	1.47e-04	174	128	5	e70cc623a3a6aceec813ed852fec0c4240561133
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CNTRL ZFAND4 ANLN CARD11 GPAT2	1.47e-04	174	128	5	b6725086fe5a2b057c7c495ec63c970ac52c2580
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CALCOCO2 PIH1D2 CFAP141 FAM81A PLPPR4	1.55e-04	176	128	5	d6d7e4e937d49a5c0d16322c8dd3bf9e97eb8732
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CALCOCO2 PIH1D2 CFAP141 FAM81A PLPPR4	1.55e-04	176	128	5	c03d80df2550c0d2b0452326480d6bf21d20fdd2
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CENPF OPTN ANLN SYNE2 KIF14	1.64e-04	178	128	5	15a99080e9f669572ab6d82934f324e6714846c1
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CENPF OPTN ANLN SYNE2 KIF14	1.64e-04	178	128	5	200308e109abb7e6f8816a6f8cce6d56862d4098
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CENPF PIH1D2 CFAP141 OPTN KATNIP	1.64e-04	178	128	5	6178706db4a855d72abc156537604d575624df56
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CENPF PIH1D2 CFAP141 OPTN KATNIP	1.64e-04	178	128	5	f02076ece0fa899e620971c887ad4da7f48684ed
ToppCell	normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	SPTBN1 EIF3E NAP1L1 GCC2 EEA1	1.64e-04	178	128	5	fa3585383a1e7da460c88a802aaa81246d681b6b
ToppCell	BAL-Mild-cDC_4\|Mild / Compartment, Disease Groups and Clusters	VPS37B SYNE2 TFB2M TAF4 CCDC144A	1.68e-04	179	128	5	68511e87b12b8253de7771e5ccfc5869248b8450
ToppCell	droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CENPF ANLN RASGEF1B KIF14 ATP13A3	1.72e-04	180	128	5	43fd5c498a87bb078d101298b472656f3294686a
ToppCell	Healthy_Control-Lymphoid-T-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	CENPF SPTBN1 SKA2 ANLN KIF14	1.77e-04	181	128	5	ac1ee313910c05b1b3cb497bae14565464919c21
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 OPTN ANLN SYNE2 KIF14	1.77e-04	181	128	5	566249e04dd491e6287ad2101b7b1ab11031ed8b
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 OPTN ANLN SYNE2 KIF14	1.77e-04	181	128	5	db9528dc7cb0230e4c36cb27da69102c588c7ee9
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN1 CNTRL TRIP11 GCC2 EIF4G3	1.81e-04	182	128	5	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	LV-07._Pericyte\|World / Chamber and Cluster_Paper	SOX13 VPS13D PLCB4 MAML2 GPAT2	1.86e-04	183	128	5	273db6a3b00a93ca852498471187b642b5368185
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TCN1 CENPF SPART ANLN KIF14	1.91e-04	184	128	5	a8c6028d745aaa6ee7842259238694cb50ce0526
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TCN1 CENPF SPART ANLN KIF14	1.91e-04	184	128	5	081d045f3bc98a36f342de7d50f39c9a888dd7eb
ToppCell	Control-Myeloid_G-immature_Neutrophil\|Control / Disease group, lineage and cell class	TCN1 CENPF SPART ANLN KIF14	1.91e-04	184	128	5	45f873236f7e90fb78c8e291d3b5b92d121acec9
Computational	Genes upregulated in subsets of cells of a given type within various tumors	AKAP9 GCC2 SYNE2 GOLGA4 GOLGB1	2.63e-05	49	78	5	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Computational	Genes upregulated in subsets of cells of a given type within various tumors	KMT2C DST AKAP9 GOLGA4 GOLGB1	2.63e-05	49	78	5	GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED
Computational	Genes upregulated in subsets of cells of a given type within various tumors	TRIP11 DST SYNE2 GOLGA4 GOLGB1	2.90e-05	50	78	5	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Computational	Neighborhood of CCNI	EIF3E NAP1L1 PRPF8 BTF3 EIF4G2	4.33e-04	88	78	5	MORF_CCNI
Computational	Neighborhood of EIF4A2	ZNF384 EIF3E NAP1L1 PRPF8 BTF3 EIF4G2	4.83e-04	138	78	6	MORF_EIF4A2
Drug	Clorgyline	DYNC2H1 TRIP11 RAD50 DST AKAP9 GCC2 POLK GOLGA4 GOLGB1 RGPD5	3.92e-08	168	128	10	ctd:D003010
Drug	1i32	EPHB2 RAD50 PABPN1 EIF4G2 EIF4G3 NBR1 GOLGB1	8.52e-06	129	128	7	CID000446186
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A	DYNC2H1 SPTBN1 RGS12 PPP3R1 EIF4G2 AFDN AKAP13 KATNIP	1.28e-05	191	128	8	7417_UP
Drug	Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; PC3; HG-U133A	CENPF NAP1L1 MTMR6 VPS13D AKAP9 ATP13A3 EIF4G3 FUBP3	1.49e-05	195	128	8	1927_UP
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; HL60; HT_HG-U133A	REX1BD EFL1 SPTBN1 TRIP11 PPP3R1 RHOBTB1 PLCB4 NAA40	1.49e-05	195	128	8	1160_DN
Drug	Amrinone [60719-84-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A	REX1BD CEP162 SPTBN1 SPART VPS37B PPP3R1 EIF4G3 GOLGA1	1.79e-05	200	128	8	3465_DN
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH1 MYH4 CENPF PPP3R1 DMD	1.93e-05	80	120	5	DOID:12930 (implicated_via_orthology)
Disease	Adenocarcinoma Of Esophagus	SPART ELMO1 PIK3CA	2.31e-05	14	120	3	C0279628
Disease	cryptorchidism (implicated_via_orthology)	SYNE2 ADAMTS16	4.91e-05	3	120	2	DOID:11383 (implicated_via_orthology)
Disease	intelligence, specific language impairment, dyslexia	CCDC136 PMFBP1	4.52e-04	8	120	2	EFO_0004337, EFO_0005424, EFO_1001510
Disease	dilated cardiomyopathy (is_implicated_in)	ISL1 PPP3R1 DMD	7.19e-04	43	120	3	DOID:12930 (is_implicated_in)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH4	7.23e-04	10	120	2	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH4	7.23e-04	10	120	2	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH4	7.23e-04	10	120	2	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH4	7.23e-04	10	120	2	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH4	7.23e-04	10	120	2	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH4	7.23e-04	10	120	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH4	7.23e-04	10	120	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH4	7.23e-04	10	120	2	DOID:0080326 (implicated_via_orthology)
Disease	Weight Gain	SPTBN1 VPS13D PIK3CA IPO11	8.13e-04	102	120	4	C0043094
Disease	Gastric cancer	CASP10 PIK3CA	8.81e-04	11	120	2	cv:C0024623
Disease	Neoplasm of stomach	CASP10 PIK3CA	8.81e-04	11	120	2	cv:C0038356
Disease	GASTRIC CANCER	CASP10 PIK3CA	8.81e-04	11	120	2	613659
Disease	specific language impairment, dyslexia	CCDC136 PMFBP1	1.05e-03	12	120	2	EFO_0005424, EFO_1001510
Disease	tryptophan betaine measurement	RAD50 IFT88	1.05e-03	12	120	2	EFO_0021017
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH4	1.05e-03	12	120	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH4	1.05e-03	12	120	2	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH4	1.24e-03	13	120	2	DOID:397 (implicated_via_orthology)
Disease	male infertility (implicated_via_orthology)	ADAMTS16 PMFBP1	1.24e-03	13	120	2	DOID:12336 (implicated_via_orthology)
Disease	Polydactyly	CENPF DYNC2H1 IFT88 PIK3CA	1.35e-03	117	120	4	C0152427
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH4	1.66e-03	15	120	2	DOID:0050646 (implicated_via_orthology)
Disease	Sarcomatoid Renal Cell Carcinoma	PIK3CA SYNE2 AKAP13 CARD11	1.88e-03	128	120	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	PIK3CA SYNE2 AKAP13 CARD11	1.88e-03	128	120	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	PIK3CA SYNE2 AKAP13 CARD11	1.88e-03	128	120	4	C1266044
Disease	Papillary Renal Cell Carcinoma	PIK3CA SYNE2 AKAP13 CARD11	1.88e-03	128	120	4	C1306837
Disease	Renal Cell Carcinoma	PIK3CA SYNE2 AKAP13 CARD11	1.88e-03	128	120	4	C0007134
Disease	thyroxine measurement, triiodothyronine measurement	EPHB2 VPS37B	2.14e-03	17	120	2	EFO_0005130, EFO_0008392
Disease	Benign neoplasm of stomach	CASP10 PIK3CA	2.14e-03	17	120	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	CASP10 PIK3CA	2.14e-03	17	120	2	C0496905
Disease	Carcinoma in situ of stomach	CASP10 PIK3CA	2.14e-03	17	120	2	C0154060
Disease	ischemia (implicated_via_orthology)	ANGPT2 SCNN1G	2.14e-03	17	120	2	DOID:326 (implicated_via_orthology)
Disease	inosine measurement	CTNNA3 DMD	2.68e-03	19	120	2	EFO_0010503
Disease	acute lymphoblastic leukemia, response to antineoplastic agent	ELMO1 MAML2	2.68e-03	19	120	2	EFO_0000220, GO_0097327
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	PIK3CA SYNE2 AKAP13 CARD11	3.18e-03	148	120	4	C0279702
Disease	stomach cancer (is_implicated_in)	CASP10 KMT2C PIK3CA	3.19e-03	72	120	3	DOID:10534 (is_implicated_in)
Disease	Stomach Carcinoma	CASP10 PIK3CA	3.27e-03	21	120	2	C0699791
Disease	Malignant neoplasm of prostate	EPHB2 PMS1 CENPF KMT2C PIK3CA AKAP13 POLK GOLGA4	3.75e-03	616	120	8	C0376358
Disease	Parkinson's disease (implicated_via_orthology)	PGK2 EIF4G2 ATP13A3 EIF4G3	3.93e-03	157	120	4	DOID:14330 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
KNFMLNQNVMLSVKG	TDRD1	1076	Q9BXT4
VSMMEGVIQKQKNIA	AFDN	671	P55196
QEPQMKETIMNQEKL	BTF3	41	P20290
QNEMSQKIETMQFEK	AKAP9	671	Q99996
IQQKQSQMLEMQVEL	AKAP9	3126	Q99996
IEENKLKLVQQEMMF	CNTRL	1936	Q7Z7A1
LKLVQQEMMFQRLQK	CNTRL	1941	Q7Z7A1
DFNKVMQVVKEQVMR	ELMO1	476	Q92556
NISEIQKLKQQLMQM	BICD2	341	Q8TD16
QIMKMRKKISNAQLQ	CUL5	721	Q93034
IGILKQAIDKMQMNT	COPS3	121	Q9UNS2
FMGLIIMQNKLKQET	ATP13A3	716	Q9H7F0
MVLNSLDKMIQLQKN	EFL1	1	Q7Z2Z2
QKKIMNSLQEMKVQL	EPHA5	1016	P54756
NSLQEMKVQLVNGMV	EPHA5	1021	P54756
IFKLMNIQQQLMKTN	AKAP13	276	Q12802
NIQQQLMKTNLKQMD	AKAP13	281	Q12802
IQDNMKKEMVEIQQN	ANGPT2	101	O15123
LKNMMVLIENEAFKQ	BTBD11	1051	A6QL63
LKMMVGNNLKDTQLQ	PPP3R1	116	P63098
KNVMKNIMAGLQQTN	DMD	121	P11532
INEMIIKQKATMQDL	DMD	2506	P11532
NVETLVVVDKKMMQN	ADAMTS16	291	Q8TE57
IQLIKNMLDKVNEMI	PGK2	221	P07205
VQIMKSLNNPAMLQV	RAVER2	341	Q9HCJ3
MEKMKCNILSQQQTE	RUBCNL	221	Q9H714
GQMQVLQMKSEHQKL	RAD50	1046	Q92878
LNMICQQVEAIKKEM	RGPD5	811	Q99666
LNMICQQVEAIKKEM	RGPD8	811	O14715
ELQMNQNIKEMKAEV	FAM81A	311	Q8TBF8
QKLISQMMAAKAIQE	IQCN	121	Q9H0B3
TKLKARQLTVQMMQN	NAP1L1	31	P55209
TTIPKMLMNIQTQNK	OR7A5	76	Q15622
VIMVGKQVINNMQEV	ANO7	646	Q6IWH7
VEQQKEQMAKLMLQR	CFAP99	381	D6REC4
AQLKAKEEMMQGIQI	KIF14	946	Q15058
VNMLMNQLNPEDKKT	FAR1	406	Q8WVX9
MVALKGINKVMAQNN	KMT2C	3101	Q8NEZ4
LEKNKTIKQMQQRML	GOLGA1	631	Q92805
IMNMNEQNKQLEKDI	MTMR6	516	Q9Y217
LMQQLEKQNSEMEQK	GOLGA4	866	Q13439
LNQQKMLVSEIEMKQ	DST	1331	Q03001
AMNQQLETAQKMKQE	DST	4771	Q03001
MMNENQIITNAKRKQ	KATNIP	1581	O60303
IKQKMQELNNEINMQ	ANLN	716	Q9NQW6
FIVQCMNLIKMIVKN	IPO11	316	Q9UI26
KILNSIQVMRAQMNQ	EPHB2	966	P29323
LEVKELKNQVQMMVQ	KIF27	501	Q86VH2
LKNQVQMMVQENKGH	KIF27	506	Q86VH2
KQLQERTGVKMVMIQ	FUBP3	186	Q96I24
RQKQKEQQQMMEAQE	GBP7	506	Q8N8V2
MVTLMQEKNDLQLQV	MYH1	881	P12882
KNVQQMMQCLIRKLA	RASGEF1B	151	Q0VAM2
QLAAVQAQMRKAMAK	HK3	496	P52790
TELFQQSKVNMQKML	EIF4G2	691	P78344
QSKVNMQKMLPEIDQ	EIF4G2	696	P78344
IQILQLMANSTQMKK	NAA40	156	Q86UY6
ETQKVQMKFLVEQMR	PIK3CA	726	P42336
QQLMGKKQTLQRQIM	MAML2	751	Q8IZL2
LKELQNEVEKQMNMS	PABPN1	136	Q86U42
AKNLMNAVVQTVKMS	CTNNA3	811	Q9UI47
QLMIKDQIEVMKGNV	DYNC2H1	1026	Q8NCM8
LKKELVQVQTLMDNM	EEA1	226	Q15075
DQVPSVNKQMRIKIM	IFT88	261	Q13099
VNKQMRIKIMQNIGV	IFT88	266	Q13099
AILQVEQKMMTQTFQ	CCDC150	376	Q8NCX0
AIQTLQMELQQIMKG	GFPT2	306	O94808
VNDLLQENEQLMKVM	CENPF	1146	P49454
LMQTQQMLLNKEEAV	FER	316	P16591
QNDQKLEKLMVQMKV	GCC2	661	Q8IWJ2
PNMKNSNVVKMLQEN	IL23R	401	Q5VWK5
FLNVQLHKGQMKMVQ	GPAT2	176	Q6NUI2
CDQLTVKLKQMENMV	CCDC144B	656	Q3MJ40
VKLKQMENMVSVLQN	CCDC144B	661	Q3MJ40
KMININILSVCKMTQ	HSD17B12	156	Q53GQ0
VEQMKQNETTAMKKQ	CALCOCO2	286	Q13137
MEKEIQQLQDMITQN	CEP95	776	Q96GE4
SLRTMEQQFQKMKIQ	CEP162	986	Q5TB80
QVMNQQLQTKAMALL	ELMO3	221	Q96BJ8
QMLAMNIEKKLNQNS	EIF3E	416	P60228
NVTKVEMEMVLQKQK	CASP10	326	Q92851
MQDTMVQELALAKKQ	CFAP141	51	Q5VU69
QIKTKDQMQMKETQP	FAM186A	981	A6NE01
CDQLTVKLKQMENMV	CCDC144A	656	A2RUR9
VKLKQMENMVSVLQN	CCDC144A	661	A2RUR9
MNKKLQNMLEEQLTK	GRIPAP1	791	Q4V328
NIMAQVPLEKKINMS	SCNN1G	236	P51170
ILNKLTPQMFNQLMK	EIF4G3	761	O43432
SQNIKMVQIPFSMKN	PMS1	691	P54277
LMNEVIKLQQQMKAK	CARD11	131	Q9BXL7
MLMNFVSKKNIISNV	OR8B2	81	Q96RD0
NLLNKIQNMKELAEM	KBTBD12	16	Q3ZCT8
MMQTKVQNKKRQVAF	PCDHB6	1	Q9Y5E3
QLQMDEMKQTIAKQE	OPTN	441	Q96CV9
RQLQKTVAEQDMKMN	PMFBP1	571	Q8TBY8
VLKKENFNMMNALDQ	FNDC8	16	Q8TC99
MRAMQQQVQKLKVKS	HSPBP1	236	Q9NZL4
QKAKEMQQQELAQMR	TAF4	986	O00268
QLVMGIQKQIDNMKG	TAF7	276	Q15545
MNMAELAQQVVKQEL	TFEB	336	P19484
NEQAKEMQQMVKLEA	PLCB4	1151	Q15147
MNMIQKLQKQTDLEL	SKA2	86	Q8WVK7
QIKQMLLKQVIRNME	SLC9C1	771	Q4G0N8
LQKKIMMETQQQEIA	SYCP3	211	Q8IZU3
QLEMNLPLMIKKQDQ	SYNE2	666	Q8WXH0
TVKCNLEKVQMMLQE	SYNE2	4321	Q8WXH0
EALKMAVKQGNQLQM	NBR1	66	Q14596
KVMQNLNLEMNNNKI	SHCBP1L	626	Q9BZQ2
RQQPKNLKAMEMQIK	TAOK3	706	Q9H2K8
LMQIGKQEDEKVVNM	TFB2M	351	Q9H5Q4
MVTLMQEKNDLQLQV	MYH4	881	Q9Y623
NIMNKEAFMNQEITK	RHOBTB1	451	O94844
DKKRSIMMKQLQQQQ	ISL1	236	P61371
QMIQQAQKVIAVVMD	FAM83F	156	Q8NEG4
MQLEQKVRGSKQMNT	SLC25A33	156	Q9BSK2
KALMMEKEQLQQQLQ	SLFNL1	381	Q499Z3
NILLKKQQMLENQME	SPTBN1	1416	Q01082
KQQMLENQMEVRKKE	SPTBN1	1421	Q01082
EEKNIQLSLEKQQMM	CCDC110	526	Q8TBZ0
KQSKLLMEQMQALQV	CCDC136	676	Q96JN2
IQQAMAKIMKANPAL	PRPF8	1726	Q6P2Q9
IMQVIAMSKQQGVLQ	PLPPR4	576	Q7Z2D5
QMFLNMTKLEKEAQV	TOP3B	271	O95985
DQVKKNQLIQMAMKC	PIH1D2	121	Q8WWB5
SLPQQKVMAQQMKKV	PLCL1	496	Q15111
SEQKNMAAMLFEKQQ	SOX13	171	Q9UN79
QMQQKMKETLQNVRT	SPART	76	Q8N0X7
GQIENTMFINKMKDQ	ZNF384	21	Q8TF68
DMFKEQQLQIFNLMK	RGS12	801	O14924
QEDAVRMQQLKMKVI	REX1BD	166	Q96EN9
ICIQQEIIKKMNAML	SYCP2	166	Q9BX26
KEKQVNQRIENMMQQ	POLK	56	Q9UBT6
IQIQTLMQKMIQQIK	TCN1	66	P20061
LMQKMIQQIKYNVKS	TCN1	71	P20061
QKIMAQMSALQKNFI	UBR1	1031	Q8IWV7
QMEEMQKAFNKTIVK	SUCO	946	Q9UBS9
KMQLLQSLQEQKKEM	TRIP11	926	Q15643
KKAVQAVNRKVEMMN	ZNF622	96	Q969S3
GQQIIENSITMNKMK	ZFAND4	211	Q86XD8
TIQKMIMDQEKQEGV	GTF3C1	636	Q12789
MVQKMEETQNVQLNK	VPS37B	31	Q9H9H4
EKQIEQQKKILMSTM	ATP6V1E2	61	Q96A05
MQNAVNEPVQKLMRK	VPS13D	181	Q5THJ4
VMMKQQLQEKEEFIS	GOLGB1	186	Q14789
MLQEEVTKMNLLNQQ	GOLGB1	1886	Q14789